Skip to main content
. 2021 Apr 15;10(4):e27382. doi: 10.2196/27382

Table 1.

Measures and timing of data collection for stage 3 randomized controlled trial.

Outcomes Baseline (during the third trimester) 4, 8, and 12 weeks postpartum
Demographic characteristics

Age a N/Ab

Education level N/A

Marital status N/A

Time in OATc program N/A

Number and age of living children N/A

Employment N/A
Baseline characteristics

Addiction Severity Index-Lite N/A

Maternal Antenatal Attachment Scale N/A
Outcome measures

Addiction Severity Index-Lite

Maternal Postpartum Attachment Scale N/A

Birth Satisfaction Scale-Revised N/A

Patient Health Questionnaire-9 N/A

Parenting Stress Index N/A

Client Satisfaction Questionnaire-8 N/A

System Usability Scale N/A

Length of hospital stay for newborn N/A

Newborn hospital readmission N/A

Breastfeeding initiation and duration N/A

Maternal OAT continuation and relapse N/A

Frequency of NASd tool use (weekly)

aData collected.

bN/A: not applicable.

cOAT: opioid agonist therapy.

dNAS: neonatal abstinence syndrome.